Sangamo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Sangamo Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Sangamo Therapeutics Inc
Rating: 1.0508055
Author: Trendlyne DVM scores

Weak Stock

about

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the P...

0.50 -0.03 (-5.66%)

84.28% Fall from 52W High

5.0M

XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

17.0 / 100

Technically Bearish

22.6 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 720%

5 analysts

Sangamo Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sangamo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the P...

84.28% Fall from 52W High

SWOT Analysis

Sangamo Therapeutics Inc Live Price Chart